Aidian logo — Aidian develops, manufactures and markets diagnostic tests a...

Aidian

Aidian develops, manufactures and markets diagnostic tests and test solutions.

Founded 1974 Finland Finland 205 employees Venture round Biotechnology, Health Care +1

General Information

Company Name Aidian
Founded Year 1974
Location Finland Finland
Employees 205
Industries Biotechnology, Health Care, Manufacturing
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Aidian. To contact Aidian, visit aidian.eu.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Aidian compare?

A PDF of Aidian and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Aidian soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Aidian

Aidian, a leading Finnish in vitro diagnostics (IVD) company founded in 1974, is dedicated to developing, manufacturing, and distributing reliable and fast diagnostic tests for point of care. With the slogan "Aidian develops, manufactures and markets diagnostic tests and test solutions," the company focuses on promoting efficient healthcare through accurate and fast diagnostics to aid global health. Aidian's core business values high-quality products and patient safety and specializes in point of care, offering solutions for infectious disease diagnostics, improved diabetes management, and colorectal cancer screening. Additionally, the company provides user-friendly hygiene monitoring products for hospitals and industries. Aidian's global footprint spans over 60 countries, with flagship products like QuikRead go® being used globally, boasting over 60,000 instruments in use by customers. The company maintains a workforce of approximately 300 dedicated employees and operates local offices in 12 countries, including Sweden, Norway, Denmark, Germany, Czech Republic, Slovakia, Hungary, Poland, the Netherlands, Belgium, Estonia, and China. Aidian is fully compliant with the ISO 13485 Quality Standard and FDA requirements, underscoring its commitment to high standards of quality and safety. In May 2022, Aidian secured a Venture Round investment from Ferd Capital, further bolstering its position in the market. With its focus on addressing antimicrobial resistance and promoting the sustainable use of antibiotics in primary care, Aidian aligns with the growing global emphasis on healthcare and disease management. For more information, interested parties can visit aidian.eu or contact [email protected]. Aidian also offers its products in the USA, with detailed product information available on aidian.eu/us/products-available-in-the-usa. Additionally, Aidian's commitment to privacy is evident through its detailed Privacy Policy available on aidian.eu/privacy/privacy-policy.

Business keywords: in vitro diagnostics, diagnostic tests, rapid POC testing, POC testing, QuikRead go, isothermal nucleic acid amplification technology, molecular biology, antimicrobial resistance, antibiotic resistance, point-of-care, hygiene monitoring tests, tests for infectious diseases, diagnostic test solutions, global footprint, international offices, patient safety, ISO 13485 Quality Standard, FDA requirements, improved management of diabetes, colorectal cancer screening

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 1
Ferd Capital
02 May 2022

Aidian Alternatives & Competitors

View All Alternatives
Aidian vs

The next generation in molecular diagnostics

Series A
6 employees
Biotechnology, Health Care
Aidian vs

We help make the world a healthier place

13122 employees
Biotechnology, Health Care
Aidian vs
True Diagnostics™
True Diagnostics™ United States

FOR POINT OF CARE ANSWERS™

17 employees
Health Care, Manufacturing

FAQ About Aidian

Aidian develops, manufactures and markets diagnostic tests and test solutions.
Aidian was founded in 1974.
Aidian is headquartered in Finland.
Aidian operates in Biotechnology, Health Care and Manufacturing. Its work centres on in vitro diagnostics, diagnostic tests, rapid POC testing, POC testing, QuikRead go, isothermal nucleic acid amplification technology, molecular biology, antimicrobial resistance, antibiotic resistance and point-of-care, hygiene monitoring tests, tests for infectious diseases, diagnostic test solutions.
Aidian has approximately 205 employees.
Aidian has completed 1 funding round. The latest funding stage is Venture round.
Top alternatives and competitors to Aidian include Tangen Biosciences, Inc., bioMérieux, True Diagnostics™, Athenese Dx Private Limited, FluoretiQ Limited. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Aidian and Tangen Biosciences, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Aidian, https://bouncewatch.com/company/aidian, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes